Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

LANSOPRAZOLE FOR PEAK IDENTIFICATION CRS (1.01 MG)

LANSOPRAZOLE FOR PEAK IDENTIFICATION CRS (1.01 MG)

103577-45-3

DISCOVER
BENZBROMARONE CRS (10 MG)

BENZBROMARONE CRS (10 MG)

3562-84-3

DISCOVER
METHYLERGOMETRINE MALEATE CRS(10 MG)

METHYLERGOMETRINE MALEATE CRS(10 MG)

57432-61-8

DISCOVER
METHYLERGOMETRINE FOR SYSTEM SUITABILITY CRS (0.53 MG)

METHYLERGOMETRINE FOR SYSTEM SUITABILITY CRS (0.53 MG)

57432-61-8

DISCOVER
WARFARIN SODIUM CLATHRATE CRS(10 MG)

WARFARIN SODIUM CLATHRATE CRS(10 MG)

NA

DISCOVER
Chlortalidone for peak identification

Chlortalidone for peak identification

77-36-1

DISCOVER
PARAFFIN (HARD) CRS (10 MG)

PARAFFIN (HARD) CRS (10 MG)

8002-74-2

DISCOVER
FOSFOMYCIN CALCIUM CRS (15 MG)

FOSFOMYCIN CALCIUM CRS (15 MG)

26469-67-0

DISCOVER
CELLULOSE ACETATE CRS (40 MG)

CELLULOSE ACETATE CRS (40 MG)

9004-35-7

DISCOVER
ROSMARINIC ACID CRS (50 MG)

ROSMARINIC ACID CRS (50 MG)

20283-92-5

DISCOVER
CAFFEINE FOR SYSTEM SUITABILITY CRS (10 MG)

CAFFEINE FOR SYSTEM SUITABILITY CRS (10 MG)

58-08-2

DISCOVER
INDINAVIR CRS (100 MG)

INDINAVIR CRS (100 MG)

157810-81-6

DISCOVER